ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation

FEBS Open Bio. 2021 Oct;11(10):2784-2799. doi: 10.1002/2211-5463.13278. Epub 2021 Sep 14.

Abstract

Hepatocellular carcinoma (HCC) is one of the most fatal cancers worldwide. In this article, we show that expression of abnormal spindle-like microcephaly-associated protein (ASPM) is up-regulated in liver cancer samples, and this up-regulation is significantly associated with tumor aggressiveness and reduced survival times of patients. Down-regulation of ASPM expression inhibits the proliferation, invasion, migration and epithelial-to-mesenchymal transition of HCC cells in vitro and inhibits tumor formation in nude mice. ASPM interacts with disheveled-2 (Dvl2) and antagonizes autophagy-mediated Dvl2 degradation by weakening the functional interaction between Dvl2 and the lipidated form of microtubule-associated proteins 1A/1B light chain 3A (LC3II), thereby increasing Dvl2 protein abundance and leading to Wnt/β-catenin signaling activation in HCC cells. Thus, our results define ASPM as a novel oncoprotein in HCC and indicate that disruption of the Wnt-ASPM-Dvl2-β-catenin signaling axis might have potential clinical value.

Keywords: ASPM; Dvl2; Wnt/β-catenin; autophagy; hepatocellular carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy
  • Carcinoma, Hepatocellular* / pathology
  • Cell Line, Tumor
  • Dishevelled Proteins / genetics
  • Dishevelled Proteins / metabolism
  • Humans
  • Liver Neoplasms* / pathology
  • Mice
  • Mice, Nude
  • Nerve Tissue Proteins / metabolism
  • beta Catenin / metabolism

Substances

  • ASPM protein, human
  • DVL2 protein, human
  • Dishevelled Proteins
  • Nerve Tissue Proteins
  • beta Catenin